Uso Terapéutico Del Cannabidiol En Caninos
Resumen
El cannabidiol (CBD), el principal compuesto no psicoactivo que se encuentra en la Cannabis Sativa, se usa con frecuencia tanto como nutracéutico como terapéutico, debido a los efectos farmacológicos que incluyen antiinflamatorio, analgésico, antipruriginoso, ansiolítico, inhibidor del crecimiento tumoral y anticonvulsivo, propiedades que han hecho de él una opción de tratamiento atractiva para evitar o disminuir los efectos secundarios de los fármacos tradicionales. Sin embargo, debido a la escasez de estudios científicos sólidos prescripción en perros es limitada, el propósito de esta investigación es describir los beneficios terapéuticos del cannabidiol en caninos a través de una revisión bibliográfica para proporcionar fiabilidad para que los veterinarios informen a sus usuarios sobre el uso y la seguridad de los productos de CBD. Se consulta e identifica los reportes más relevantes del cannabidiol en perros, seleccionando así la información de su uso terapéutico, describiendo sus características, propiedades, dosificación, vías de administración y eventos adversos. Se discute con ensayos clínicos y resultados basado en evidencia experimental.
Descargas
Citas
Achi Santibañez, A. M., & Macay Castro, K. E. (2021). Efecto analgésico del aceite cannabidiol (CBD) en el post operatorio de ooforosalpingohisterectomía en cannis familiaris (Bachelor's thesis, Calceta: ESPAM MFL).
American Veterinary Medical Association - AVMA. (2019). Cannabis Use and Pets. https://www.avma.org/resources-tools/veterinarians-and-public-health/cannabis-use-and-
American Veterinary Medical Association - AVMA. (2020). Cannabis in veterinary medicine. https://www.avma.org/sites/default/files/2021-03/APH-CannabisResources-Report-
Bartner, L. R., McGrath, S., Rao, S., Hyatt, L. K., & Wittenburg, L. A. (2018). Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs. Canadian Journal of Veterinary Research, 82(3), 178-183
Brioschi, F. A., Di Cesare, F., Gioeni, D., Rabbogliatti, V., Ferrari, F., D’Urso, E. S., ... & Ravasio, G. (2020). Oral transmucosal cannabidiol oil formulation as part of a multimodal analgesic regimen: effects on pain relief and quality of life improvement in dogs affected by spontaneous osteoarthritis. Animals, 10(9), 1505.
Brutlag, A., & Hommerding, H. (2018). Toxicology of marijuana, synthetic cannabinoids, and cannabidiol in dogs and cats. Veterinary Clinics: Small Animal Practice, 48(6), 1087- 1102.
Campora, L., Miragliotta, V., Ricci, E., Cristino, L., Di Marzo, V., Albanese, F., ... & Abramo,
F. (2012). Cannabinoid receptor type 1 and 2 expression in the skin of healthy dogs and dogs with atopic dermatitis. American journal of veterinary research, 73(7), 988-995.
Corsetti, S., Borruso, S., Malandrucco, L., Spallucci, V., Maragliano, L., Perino, R., ... & Natoli,
E. (2021). Cannabis sativa L. may reduce aggressive behaviour towards humans in shelter dogs. Scientific reports, 11(1), 1-10.
De Briyne, N., Holmes, D., Sandler, I., Stiles, E., Szymanski, D., Moody, S., ... & Anadón, A. (2021). Cannabis, Cannabidiol Oils and Tetrahydrocannabinol—What Do Veterinarians Need to Know? Animals, 11(3), 892.
Deabold, K. A., Schwark, W. S., Wolf, L., & Wakshlag, J. J. (2019). Single-dose pharmacokinetics and preliminary safety assessment with use of CBD-rich hemp nutraceutical in healthy dogs and cats. Animals, 9(10), 832.
Dixit, V. P., Gupta, C. L., & Agrawal, M. (1977). Testicular degeneration and necrosis induced by chronic administration of cannabis extract in dogs. Endokrinologie, 69(3), 299-305.
Dos Santos, R. G., Hallak, J. E., & Crippa, J. A. S. (2021). Neuropharmacological effects of the main phytocannabinoids: a narrative review. Cannabinoids and neuropsychiatric disorders, 29-45.
Fernández-Trapero, M., Pérez-Díaz, C., Espejo-Porras, F., de Lago, E., & Fernández-Ruiz, J. (2020). Pharmacokinetics of Sativex® in dogs: Towards a potential cannabinoid-based therapy for canine disorders. Biomolecules, 10(2), 279.
Figueiredo, A. S., García-Crescioni, H. J., Bulla, S. C., Ross, M. K., McIntosh, C., Lunsford, K., & Bulla, C. (2013). Suppression of vascular endothelial growth factor expression by cannabinoids in a canine osteosarcoma cell line. Veterinary Medicine: Research and Reports, 4, 31-34.
Gamble, L. J., Boesch, J. M., Frye, C. W., Schwark, W. S., Mann, S., Wolfe, L., ... & Wakshlag,
J. J. (2018). Pharmacokinetics, safety, and clinical efficacy of cannabidiol treatment in osteoarthritic dogs. Frontiers in veterinary science, 165.
García, G.A., Kube, S., Carrera-Justiz, S., Tittle, D., Wakshlag, J.J. (2022). Safety and efficacy of cannabidiol-cannabidiolic acid rich hemp extract in the treatment of refractory epileptic seizures in dogs. Frontiers in Veterinary Science 29, 9.
Gross, C., Ramirez, D., Dickinson, P., Gustafson, D., & McGrath, S. (2020). Cannabidiol induces apoptosis and perturbs mitochondrial function in both human and canine glioma cells. The FASEB Journal, 34(S1), 1-1.
Hannon, M. B., Deabold, K. A., Talsma, B. N., Lyubimov, A., Iqbal, A., Zakharov, A., ... & Wakshlag, J. J. (2020). Serum cannabidiol, tetrahydrocannabinol (THC), and their native acid derivatives after transdermal application of a low‐THC Cannabis sativa extract in beagles. Journal of Veterinary Pharmacology and Therapeutics, 43(5), 508-511.
Hartsel, J. A., Boyar, K., Pham, A., Silver, R. J., & Makriyannis, A. (2019). Cannabis in Veterinary Medicine: Cannabinoid Therapies for Animals. Nutraceuticals in Veterinary Medicine, 121–155
Hazzah, T., Andre, C., Richter, G., McGrath, S., & Collins, F. (2020). Cannabis in veterinary medicine: a critical review. AHVMA, 61, 25.
Henry, J. G., Shoemaker, G., Prieto, J. M., Hannon, M. B., & Wakshlag, J. J. (2021). The effect of cannabidiol on canine neoplastic cell proliferation and mitogen‐activated protein kinase activation during autophagy and apoptosis. Veterinary and Comparative Oncology, 19(2), 253-265
Hernández-Sampieri, R., Fernández-Collado, C., & Baptista-Lucio, P. (2017). Desarrollo de la perspectiva teórica: revisión de la literatura y construcción del marco teórico.
Jeong, S., Jo, M. J., Yun, H. K., Kim, D. Y., Kim, B. R., Kim, J. L., et al. (2019). Cannabidiol Promotes Apoptosis via Regulation of XIAP/Smac in Gastric Cancer. Cel Death Dis. 10, 846.
Klean-Vet. (20 de mayo de 2022). El cannabis medicinal de uso veterinario es una realidad en Colombia. Klean-Vet. https://klean-vet.com/
Kogan LR. (2018). Dog owners' use and perceptions of cannabis products. J Amer Hol Med Assoc. 51, 26–33.
Kogan, L. R., Hellyer, P. W., Silcox, S., & Schoenfeld-Tacher, R. (2019). Canadian dog owners’ use and perceptions of cannabis products. The Canadian Veterinary Journal, 60(7), 749.
Kogan, L., Hellyer, P., & Downing, R. (2020). The use of cannabidiol-rich hemp oil extract to treat canine osteoarthritis-related pain: a pilot study. AHVMA J, 58, 1-10.
Kogan, L., Schoenfeld-Tacher, R., Hellyer, P., & Rishniw, M. (2019). US veterinarians' knowledge, experience, and perception regarding the use of cannabidiol for canine medical conditions. Frontiers in Veterinary Science, 338.
Landa, L., Sulcova, A., & Gbelec, P. (2016). The use of cannabinoids in animals and therapeutic implications for veterinary medicine: a review. Veterinární medicína, 61(3).
Maroon, J., & Bost, J. (2018). Review of the neurological benefits of phytocannabinoids. Surgical neurology international, 9.
McGrath, S., Bartner, L. R., Rao, S., Kogan, L. R., & Hellyer, P. W. (2018). A report of adverse effects associated with the administration of cannabidiol in healthy dogs. Vet Med, 1, 6-8. McGrath,
S., Bartner, L. R., Rao, S., Packer, R. A., & Gustafson, D. L. (2019). Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy. Journal of the American Veterinary Medical Association, 254(11), 1301-1308.
Mejia, S., Duerr, F. M., Griffenhagen, G., & McGrath, S. (2021). Evaluation of the effect of cannabidiol on naturally occurring osteoarthritis-associated pain: a pilot study in dogs. Journal of the American Animal Hospital Association, 57(2), 81-90.
Milando, R., & Friedman, A. (2019). Cannabinoids: potential role in inflammatory and neoplastic skin diseases. American journal of clinical dermatology, 20(2), 167-180.
Morris, E. M., Kitts-Morgan, S. E., Spangler, D. M., Gebert, J., Vanzant, E. S., McLeod, K. R., & Harmon, D. L. (2021). Feeding cannabidiol (CBD)-containing treats did not affect canine daily voluntary activity. Frontiers in Veterinary Science, 8.
Morris, E. M., Kitts-Morgan, S. E., Spangler, D. M., McLeod, K. R., Costa, J. H., & Harmon, D.
L. (2020). The impact of feeding cannabidiol (CBD) containing treats on canine response to a noise-induced fear response test. Frontiers in Veterinary Science, 690.
Olivas-Aguirre, M., Torres-López, L., Valle-Reyes, J. S., Hernández-Cruz, A., Pottosin, I., and Dobrovinskaya, O. (2019). Cannabidiol Directly Targets Mitochondria and Disturbs Calcium Homeostasis in Acute Lymphoblastic Leukemia. Cel Death Dis. 10, 779.
Parker, C. R. (2021). The Safety and Use of Cannabidiol Products in Dogs and Cats: A Literature Review.
Polidoro, D., Temmerman, R., Devreese, M., Charalambous, M., Ham, L. V., Cornelis, I., ... & Bhatti, S. F. (2022). Pharmacokinetics of cannabidiol following intranasal, intrarectal, and oral administration in healthy dogs. Frontiers in Veterinary Science, 730.
Potschka, H., Bhatti, S. F., Tipold, A., & McGrath, S. (2022). Cannabidiol in canine epilepsy. The Veterinary Journal, 10591
Rázuri Zambrano, I., & Rugel González, D. (2021). Uso terapéutico del cannabidiol en animales de compañía. Percepción de profesionales veterinarios de Guayaquil, Ecuador. Revista de Investigaciones Veterinarias del Perú, 32(6).
Rumple, S. (2018). High Time for cannabis research. Trends Magazine, American Animal Hospital Association, 29-34
Samudre, S., Hosseini, A., & Lattanzio, F. (2014). Cannabinoids: a novel treatment for glaucoma. Acta Ophthalmologica, 92.
Simpson, A. C., Bradley, C. W., & Schissler, J. R. (2020). Probable cutaneous adverse drug reaction due to a cannabidiol‐containing hemp oil product in a dog. Veterinary Dermatology, 31(5).
Universidad de la Salle. (2021). "Guía: Normas APA Séptima 7.ª Edición 2020", Recursos bibliográficos. 11. https://ciencia.lasalle.edu.co/recursos_bibliograficos/11
Vaughn, D. (2020). CBD for Dogs and Cats—What’s New?. Trends In Veterinary Nursing. https://todaysveterinarynurse.com/wp-content/uploads/sites/3/2020/03/Vaughan_CBD_TVNSpring2020.pdf
Vaughn, D. M., Paulionis, L. J., & Kulpa, J. E. (2021). Randomized, placebo-controlled, 28-day safety and pharmacokinetics evaluation of repeated oral cannabidiol administration in healthy dogs. American Journal of Veterinary Research, 82(5), 405-416.
Vaughn, D., Kulpa, J., & Paulionis, L. (2020). Preliminary investigation of the safety of escalating cannabinoid doses in healthy dogs. Frontiers in Veterinary Science, 7, 51.
Velasco, G., Sánchez, C., & Guzmán, M. (2015). Endocannabinoids and cancer. Endocannabinoids, 449-472. https://pubmed.ncbi.nlm.nih.gov/26408171/
Verrico, C. D., Wesson, S., Konduri, V., Hofferek, C. J., Vazquez-Perez, J., Blair, E., ... & Halpert, M. M. (2020). A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain. Pain, 161(9), 2191.
Wakshlag, J. J., Schwark, W. S., Deabold, K. A., Talsma, B. N., Cital, S., Lyubimov, A., ... & Zakharov, A. (2020). Pharmacokinetics of cannabidiol, cannabidiolic acid, Δ9- tetrahydrocannabinol, tetrahydrocannabinolic acid and related metabolites in canine serum after dosing with three oral forms of hemp extract. Frontiers in Veterinary Science, 505.
Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., ... & Kleijnen, J. (2015). Cannabinoids for medical use: a systematic review and meta-analysis. Jama, 313(24), 2456-2473.
Derechos de autor 2024 José Manuel Bernal Roa, Daniel Julián Noreña Valencia , María Angelica Cardozo Niño, David Orlando Gutiérrez Guauta , Gabriel Antonio Bohorquez
Esta obra está bajo licencia internacional Creative Commons Reconocimiento 4.0.
.png)
.png)
1.png)
